Results 101 to 110 of about 6,996 (143)
Olfactory Dysfunction After SARS-CoV-2 Infection in the RECOVER Adult Cohort.
JAMA Netw OpenHorwitz LI, Becker JH, Huang W, Akintonwa T, Hornig-Rohan MM, Maranga G, Adams DR, Albers MW, Ayache M, Berry J, Brim H, Bryan TW, Charney AW, Clark RA, Cortez MM, D'Anza B, Davis H, Donohue SE, Erdmann N, Flaherman V, Fong TG, Frontera JA, Goldberg MP, Goldman JD, Harkins MS, Hodder SL, Jacoby VL, Jagannathan P, Jia X, Kelly JD, Krishnan JA, Kumar A, Laiyemo AO, Levitan EB, Martin JN, McCaffrey KM, McComsey GA, Metz TD, Murthy G, Nguyen H, Okumura M, Parry S, Parthasarathy S, Patterson TF, Peluso MJ, Sorochinsky C, Walker T, Wiegand SL, Wiley Z, Wisnivesky J, Ashktorab H, Foulkes A, Lee-Iannotti JK, Researching COVID to Enhance Recovery Consortium. +53 moreeuropepmc +1 more sourceRegional Practice Variation and Outcomes in the Standard Versus Accelerated Initiation of Renal Replacement Therapy in Acute Kidney Injury (STARRT-AKI) Trial: A Post Hoc Secondary Analysis. [PDF]
Crit Care ExplorVaara ST, Serpa Neto A, Bellomo R, Adhikari NKJ, Dreyfuss D, Gallagher M, Gaudry S, Hoste E, Joannidis M, Pettilä V, Wang AY, Kashani K, Wald R, Bagshaw SM, Ostermann M, STandard vs. Accelerated initiation of Renal Replacement Therapy in Acute Kidney Injury (STARRT-AKI) Investigators . +15 moreeuropepmc +1 more sourceBiomarker-Guided Antibiotic Duration for Hospitalized Patients With Suspected Sepsis: The ADAPT-Sepsis Randomized Clinical Trial.
JAMADark P, Hossain A, McAuley DF, Brealey D, Carlson G, Clayton JC, Felton TW, Ghuman BK, Gordon AC, Hellyer TP, Lone NI, Manazar U, Richards G, McCullagh IJ, McMullan R, McNamee JJ, McNeil HC, Mouncey PR, Naisbitt MJ, Parker RJ, Poole RL, Rostron AJ, Singer M, Stevenson MD, Walsh TS, Welters ID, Whitehouse T, Whiteley S, Wilson P, Young KK, Perkins GD, Lall R, ADAPT-Sepsis Collaborators. +32 moreeuropepmc +1 more source
